Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)

1. Sanduzzi-Zamparelli,M.
2. Matilla,A.
3. Lledo,J.L.
4. Muñoz-Martínez,S.
5. Varela,M.
6. Iñarrairaegui,M.
7. Perelló,C.
8. Mínguez,B.
9. Llarch,N.
10. Márquez,L.
11. Guerrero,A.
12. Iserte,G.
13. Castaño-García,A.
14. Carrión,L.
15. Fortuny,M.
16. Rimola,J.
17. García-Criado,Á.
18. Domenech,G.
19. Torres,F.
20. Rios-Guillermo,J.
21. Boix,L.
22. Samper,E.
23. Kateb,À.
24. Bruix,J.
25. Reig,M.

Export

Export ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export ×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo lock_openRUO handle

DOI: 10.1111/APT.70578 GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/10651/85556

Data source: Scopus